{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-000009","form_type":"8-K","ticker":"CPMV","cik":"0000836564","company_name":"Mosaic ImmunoEngineering Inc.","filed_at":"2025-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.483041+00:00","generated_at":"2026-05-28T19:18:03.353396+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Mosaic ImmunoEngineering extends Oncotelic acquisition term sheet to June 30, 2025","bullets":["Binding term sheet for acquisition of Oncotelic's necroptosis cancer therapies and AI tech extended to June 30, 2025.","Original deal: $15M stock issuance at closing plus up to $15M milestone shares.","Extension allows more time for due diligence and drafting definitive agreements; no guarantee a deal will close.","Parties continue negotiating; prior expiration was December 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-000009","json":"https://secwatch.observer/filing/0001683168-25-000009.json","markdown":"https://secwatch.observer/filing/0001683168-25-000009.md","text":"https://secwatch.observer/filing/0001683168-25-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/836564/000168316825000009/0001683168-25-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/836564/000168316825000009/mosaic_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T19:18:03.353396+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}